Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cancer Research|August 3, 2005
A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641EBrian P Rubin, Cristina R Antonescu, James P Scott-Browne, et al.Blood|October 7, 2024
Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapyDavid G Coffey, Pinar Ataca Atilla, Erden Atilla, et al.Biorxiv : the Preprint Server for Biology|July 29, 2026
Enhanced BCMA Antigen Density Increases Trogocytosis and Attenuates CAR T cell FunctionPinar Ataca Atilla, Sylvain Simon, Erden Atilla, et al.Leukemia|April 27, 2022
Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignanciesGeorge S Laszlo, Johnnie J Orozco, Allie R Kehret, et al.Blood|March 2, 2026
CSF-1R inhibition and lenalidomide synergize to promote myeloma control after autologous stem cell transplantationSimone Minnie, Kenneth Ho, Julie R Boiko, et al.Blood|January 31, 2024
Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantationShuichiro Takahashi, Simone A Minnie, Kathleen S Ensbey, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2026
CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine LymphomaShyril O'Steen, Sang Y Lee, Melissa L Comstock, et al.Blood|September 28, 2019
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myelomaMargot J Pont, Tyler Hill, Gabriel O Cole, et al.Blood|November 22, 2017
CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignanciesDamian J Green, Shyril O'Steen, Yukang Lin, et al.Blood|August 10, 2019
The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease modelShyril O'Steen, Melissa L Comstock, Johnnie J Orozco, et al.Pageof 1